How an Opioid Settlement Hinders Patients’ Access to ADHD Medication and Other Drugsnews2023-03-13T07:00:10+00:00March 13th, 2023|The New York Times|
Walgreens Faces Blowback for Not Offering Abortion Pill in 21 Statesnews2023-03-08T02:48:07+00:00March 8th, 2023|The New York Times|
Walgreens Says It Won’t Offer the Abortion Pill Mifepristone in Conservative Statesnews2023-03-03T22:35:56+00:00March 3rd, 2023|The New York Times|
Narcan Is Safe to Sell Over the Counter, Advisers to the FDA Concludenews2023-02-16T01:23:11+00:00February 16th, 2023|The New York Times|
A Farmer Secretly Paid for His Neighbors’ Prescriptions for Yearsnews2023-01-25T11:35:45+00:00January 25th, 2023|The New York Times|
Abortion Pills Can Now Be Offered at Retail Pharmacies, F.D.A. Saysnews2023-01-04T03:19:55+00:00January 4th, 2023|The New York Times|
China’s Abrupt Covid Pivot Leaves Many Without Medicinesnews2022-12-20T10:30:40+00:00December 20th, 2022|The New York Times|
Walmart Agrees to Pay $3.1 Billion to Settle Opioid Lawsuitsnews2022-11-15T19:30:25+00:00November 15th, 2022|The New York Times|
CVS and Walgreens Near $10 Billion Deal to Settle Opioid Casesnews2022-11-02T21:46:14+00:00November 2nd, 2022|The New York Times|
F.D.A. Confirms Widespread Shortages of Adderallnews2022-10-13T18:04:42+00:00October 13th, 2022|The New York Times|